Sorcin promotes proliferation of hepatocellular carcinoma by regulating VEGFA/B via PI3K pathway

• Autores: Huan Zhang, Shanshan Hui, Jaceline Gislaine Pires Sanches, Yizhi Liu, Yunyi Wei, Chunwen Pu, Jun Zhang
• Localización: Journal of physiology and biochemistry, ISSN-e 1877-8755, ISSN 1138-7548, Vol. 80, Nº. 2, 2024, págs. 381-392
• Idioma: inglés
• Enlaces
  • Texto completo (pdf)
• Resumen

  • Hepatocellular carcinoma (HCC) is a highly vascularized tumor, one of the most common and lethal cancer-related tumor deaths worldwide, with cell proliferation playing a key role. In this study our western blot results and data from TAGC demonstrate a strong association between Sorcin (SRI) overexpression and poor outcomes in HCC. Moreover, SRI overexpression was remarkably effective in promoting proliferation in vitro and increasing tumor growth in vivo, which were attenuated by knocking down SRI. Mechanistically, SRI regulated vascular endothelial growth factor A (VEGFA) and vascular endothelial growth factor B (VEGFB) through PI3K/Akt/FOXO1 signal pathway. Overall, our study indicates that SRI stimulates HCC growth by controlling VEGFA/B, which presents a fresh insight into the pathogenesis of hepatocarcinogenesis and a new therapeutic target for HCC.